2017
DOI: 10.5582/ddt.2016.01064
|View full text |Cite
|
Sign up to set email alerts
|

Rivaroxaban-induced chest wall spontaneous expanding hematoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 14 publications
(29 reference statements)
0
1
0
Order By: Relevance
“…Although factor Xa inhibitors are quite popular, there are cases emerging of its rare adverse effects (i.e., exsanguination), especially in patients with hypertension, heart failure, coronary heart disease, and impaired renal and/or hepatic function and those with certain types of cancers [16]. Animal models are exposing other mechanisms that affect the efficacy of rivaroxaban; in one mouse model, rivaroxaban's anticoagulant effect was augmented by angiotensin II [17].…”
Section: Discussionmentioning
confidence: 99%
“…Although factor Xa inhibitors are quite popular, there are cases emerging of its rare adverse effects (i.e., exsanguination), especially in patients with hypertension, heart failure, coronary heart disease, and impaired renal and/or hepatic function and those with certain types of cancers [16]. Animal models are exposing other mechanisms that affect the efficacy of rivaroxaban; in one mouse model, rivaroxaban's anticoagulant effect was augmented by angiotensin II [17].…”
Section: Discussionmentioning
confidence: 99%